| Literature DB >> 28804636 |
Suruchi Batra1, Caitlin Yee2, Bernadette Diez3, Nicholas Nguyen3, Michael J Sheridan4, Mark Tufano3, Natalie Sikka3, Stacie Townsend3, Suchitra Hourigan3.
Abstract
OBJECTIVES: To assess how often obesity is acknowledged at pediatric gastroenterology outpatient visits.Entities:
Keywords: Pediatric gastroenterology; children; obesity; obesity comorbidity; overweight
Year: 2017 PMID: 28804636 PMCID: PMC5533254 DOI: 10.1177/2050312117722170
Source DB: PubMed Journal: SAGE Open Med ISSN: 2050-3121
Barriers to addressing obesity: provider survey results.
| Question | Disagree/strongly disagree | Neutral | Agree/somewhat agree |
|---|---|---|---|
| I do not have time in a clinic visit to address obesity when a patient is being seen for another diagnosis | 2/8 | 3/8 | 3/8 |
| I feel that obesity should not be managed by gastroenterology | 5/8 | 1/8 | 2/8 |
| I do not want to make the patient feel self-conscious by talking about obesity when patient is being seen for another diagnosis | 4/8 | 2/8 | 2/8 |
| I do not feel obesity should be addressed at a first clinic visit if a patient is being seen for another diagnosis | 5/8 | 1/8 | 2/8 |
| I do not feel comfortable discussing obesity with patients and giving recommendations to treat obesity | 8/8 | 0/8 | 0/8 |
| It is the job of the primary care doctor to diagnose, discuss, and treat obesity | 3/8 | 2/8 | 3/8 |
| I do not feel we have the resources to offer to help patients with obesity | 1/8 | 2/8 | 5/8 |
| I only address obesity when the patient’s BMI is severe (BMI > 99th percentile) | 7/8 | 1/8 | 0/8 |
| I only address obesity when the patient has a comorbidity, such as fatty liver, NASH, and diabetes | 6/8 | 1/8 | 1/8 |
BMI: body mass index; NASH: non-alcoholic steatohepatitis.
Figure 1.Demographics—age and gender distribution.
Factors associated with a diagnosis of obesity.
| Category | Subcategory | No (f) (% of cohort) | No | Yes (f) | Yes (% of cohort) | p-value |
|---|---|---|---|---|---|---|
| Age (n = 132) | 0.002 | |||||
| 3–5 years | 0/5 | 0.0 | 5/5 | 3.8 | ||
| 6–8 years | 5/10 | 3.8 | 5/10 | 3.8 | ||
| 9–11 years | 5/19 | 3.8 | 14/19 | 10.6 | ||
| 11–15 years | 33/62 | 25.0 | 29/62 | 22.0 | ||
| 16–20 years | 24/36 | 18.2 | 12/36 | 9.1 | ||
| Sex (n = 132) | 0.02 | |||||
| Female | 35/56 | 26.5 | 21/56 | 15.9 | ||
| Male | 32/76 | 24.2 | 44/76 | 33.3 | ||
| Ethnicity (n = 132) | 0.07 | |||||
| Declined | 3/8 | 2.3 | 5/8 | 3.8 | ||
| Hispanic/Latino | 11/39 | 8.3 | 28/39 | 21.2 | ||
| Non-Hispanic/Non-Latino | 32/45 | 24.2 | 13/45 | 9.9 | ||
| Unavailable | 21/40 | 15.9 | 19/40 | 14.4 | ||
| Race (n = 132) | 0.07 | |||||
| >1 Race | 4/6 | 3.0 | 2/6 | 1.5 | ||
| Asian | 1/3 | 0.8 | 2/3 | 1.5 | ||
| Black/African American | 6/8 | 4.6 | 2/8 | 1.5 | ||
| Declined | 2/5 | 1.5 | 3/5 | 2.3 | ||
| Hispanic/Latino | 15/39 | 11.4 | 24/39 | 18.2 | ||
| Other | 8/21 | 6.1 | 13/21 | 9.9 | ||
| Unavailable | 4/11 | 3.0 | 7/11 | 5.3 | ||
| White/Caucasian | 27/39 | 20.5 | 12/39 | 9.1 | ||
| Location (n = 128) | 0.01 | |||||
| (Frequency missing = 4) | A | 34/76 | 26.6 | 42/76 | 32.8 | |
| B | 12/24 | 9.4 | 12/24 | 9.4 | ||
| C | 6/14 | 4.7 | 8/14 | 6.3 | ||
| D | 13/14 | 10.2 | 1/14 | 0.8 | ||
| Provider (n = 132) | (11 providers analyzed) | 0.0005 | ||||
| Total | 67/132 | 50.8 | 65/132 | 49.2 | ||
| BMI ⩾99th% (n = 132) | 0.3 | |||||
| No | 61/116 | 46.2 | 55/116 | 41.7 | ||
| Yes | 6/16 | 4.6 | 10/16 | 7.6 | ||
| Referral (n = 123) | 0.01 | |||||
| (Frequency missing = 9) | Fatty liver/ALT | 4/22 | 3.3 | 18/22 | 14.6 | |
| Obese/overweight/weight gain | 2/4 | 1.6 | 2/4 | 1.6 | ||
| Other | 60/97 | 48.8 | 37/97 | 30.4 | ||
| Obesity comorbidity (n = 132) | 0.0004 | |||||
| No | 58/96 | 43.9 | 38/96 | 28.8 | ||
| Yes | 9/36 | 6.8 | 27/36 | 20.5 | ||
| Plan given (n = 132) | 0.0001 | |||||
| No | 49/63 | 37.1 | 14/63 | 10.6 | ||
| Yes | 18/69 | 13.6 | 51/69 | 38.6 | ||
| Raised ALT (IU/L) (n = 104) | 0.005 | |||||
| (Frequency missing = 28) | No | 39/63 | 37.5 | 24/63 | 12.5 | |
| Yes | 13/41 | 23.1 | 28/41 | 26.9 | ||
| Total cholesterol (mg/dL) (n = 61) | 0.98 | |||||
| (Frequency missing = 71) | Borderline (170–199) | 5/17 | 8.2 | 12/17 | 19.7 | |
| High (⩾200) | 3/6 | 4.9 | 3/6 | 4.9 | ||
| Normal (<170) | 14/38 | 23.0 | 24/38 | 39.3 | ||
| Triglycerides (mg/dL) (n = 59) | 0.02 | |||||
| (Frequency missing = 73) | Borderline (150–199) | 4/13 | 6.8 | 9/13 | 15.3 | |
| High (⩾200) | 1/10 | 1.7 | 8/10 | 30.5 | ||
| Normal (<150) | 18/36 | 30.5 | 18/36 | 30.5 | ||
| 25-OH vitamin D (ng/mL) (n = 44) | 0.02 | |||||
| (Frequency missing = 88) | Deficient (⩾10–20) | 1/3 | 2.3 | 2/3 | 4.6 | |
| Insufficient (⩾20–30) | 14/27 | 31.8 | 13/27 | 29.6 | ||
| Severely deficient (<10) | 4/4 | 9.1 | 0/4 | 0.0 | ||
| Sufficient (⩾30) | 2/10 | 4.6 | 8/10 | 18.2 |
BMI: body mass index; ALT: alanine aminotransferase.